ENGLEWOOD, Colo., April 7 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release ...
LAS VEGAS, July 15, 2021 /PRNewswire/ -- DelveInsight's Automated Compounding Device (Oncology) Market Insights and Forecast report provides the current and forecast Automated Compounding Device ...
ENGLEWOOD, Colo., Nov. 2, 2011 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, has released a software upgrade for its ExactaMix® ...
Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The "Automated Compounding Devices Market by Type, Application, End User, Distribution Channel, Software Type, Workflow Type - Global Forecast to 2030" ...
Ottawa, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The global automated pharmacy compounding systems market size is calculated at USD 3.12 billion in 2026 and is expected to reach around USD 5.27 billion by ...
The steep rise in the Automated Compounding Device (Oncology) Market can be ascribed to the emergent need to reduce medicinal errors and a growing preference of cancer patients for personalized ...
Hospital pharmacies worldwide use ExactaMix 2400 (EM2400) and ExactaMix 1200 (EM1200) to compound large- and small-volume parenteral doses. Baxa Corporation leads the ACD category with 65% of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results